LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW
200,000
-1,500 (-0.74%)
Apr 24, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
New Drug Research and Development | 121.16B | 105.36B | 12.80B | 13.08B | 12.93B | | | | | |
New Drug Research and Development Growth | 15.00% | 722.86% | -2.12% | 1.16% | -59.32% | | | | | |
| 20.39B | 20.54B | 21.34B | 20.33B | 19.23B | | | | | |
Pharmaceutical Business Growth | -0.71% | -3.76% | 4.97% | 5.75% | -25.22% | | | | | |
| 141.55B | 125.90B | 34.15B | 33.41B | 32.16B | | | | | |
| 12.43% | 268.71% | 2.20% | 3.90% | -44.07% | | | | | |
Source: S&P Global Market Intelligence.
